Jacqualyn Fouse - Mar 10, 2025 Form 4 Insider Report for MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Role
Director
Signature
/s/ Mardi Dier, as Attorney-in-Fact
Stock symbol
MDGL
Transactions as of
Mar 10, 2025
Transactions value $
$0
Form type
4
Date filed
3/12/2025, 04:29 PM
Previous filing
Jun 24, 2024
Next filing
Apr 10, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDGL Common Stock Award $0 +894 $0.00 894 Mar 10, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDGL Stock Option (Right to Buy) Award $0 +1.58K $0.00 1.58K Mar 10, 2025 Common Stock 1.58K $329.16 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units, which vest as to 50% of the shares on each of March 10, 2026 and March 10, 2027, provided the Reporting Person continues in service with the Issuer on each such date.
F2 The option vests as to 50% of the shares on the first anniversary of the date of grant (March 10, 2026) and, thereafter, 12.5% of the shares shall vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.